Serum donor | Age at vaccination | Gender | Interval following vaccination (Month) | NAbs titer against rVSV-HTNV-GP (PRNT50) | NAbs titer against HTNV 76–118 strain (FRNT50) | ||
---|---|---|---|---|---|---|---|
Decimal | Log10 | Decimal | Log10 | ||||
Vaccinee #1 | 50 | Female | 1 | 1648 | 3.217 | 122.6 | 2.089 |
11 | 1407 | 3.148 | 18.69 | 1.272 | |||
22 | 917.3 | 2.963 | 80.87 | 1.908 | |||
35 | 1171 | 3.068 | 43.21 | 1.636 | |||
46 | 426.9 | 2.63 | 44.32 | 1.647 | |||
Vaccinee #2 | 59 | Male | 2 | 1948 | 3.29 | 292.5 | 2.466 |
17 | 111.6 | 2.048 | 36.24 | 1.559 | |||
22 | 598.9 | 2.777 | 87.46 | 1.942 | |||
46 | 225 | 2.352 | 99.11 | 1.996 | |||
57 | 339.5 | 2.531 | 120.5 | 2.081 | |||
Vaccinee #3 | 54 | Female | 1 | 105.6 | 2.024 | 72.31 | 1.859 |
8 | 426.4 | 2.63 | 59.22 | 1.772 | |||
22 | 33.56 | 1.526 | 30.13 | 1.479 | |||
34 | 21.54 | 1.333 | 25.52 | 1.407 | |||
47 | 29.18 | 1.465 | 17.88 | 1.252 | |||
Vaccinee #4 | 56 | Female | 1 | 1018 | 3.008 | 65.54 | 1.817 |
8 | 911.6 | 2.96 | 22 | 1.342 | |||
22 | 180 | 2.255 | 12.81 | 1.107 | |||
34 | 134 | 2.127 | 23.6 | 1.373 | |||
47 | 167 | 2.223 | 22.28 | 1.348 | |||
Vaccinee #5 | 39 | Female | 1 | 7602 | 3.881 | 216.9 | 2.336 |
8 | 3516 | 3.546 | 85.11 | 1.93 | |||
22 | 291.9 | 2.465 | 21.66 | 1.336 | |||
33 | 3460 | 3.539 | 66.26 | 1.821 | |||
46 | 1696 | 3.229 | 81.73 | 1.912 |